Ercros, S.A. (BME:ECR)

Spain flag Spain · Delayed Price · Currency is EUR
3.420
+0.010 (0.29%)
Apr 28, 2026, 5:35 PM CET
10.50%
Market Cap 311.80M
Revenue (ttm) 628.69M
Net Income (ttm) -53.59M
Shares Out 91.44M
EPS (ttm) -0.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,797
Average Volume 43,878
Open 3.410
Previous Close 3.410
Day's Range 3.410 - 3.420
52-Week Range 2.230 - 3.475
Beta 0.27
RSI 52.99
Earnings Date Feb 27, 2026

About Ercros

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides ... [Read more]

Industry Chemicals
Sector Materials
Founded 1817
Employees 1,329
Stock Exchange Madrid Stock Exchange
Ticker Symbol ECR
Full Company Profile

Financial Performance

In 2025, Ercros's revenue was 628.69 million, a decrease of -5.92% compared to the previous year's 668.22 million. Losses were -53.59 million, 359.7% more than in 2024.

Financial Statements

News

There is no news available yet.